Shareholder Votes

SurgePays, Inc. shareholders approved Approval of terms of securities purchase agreements and issuance of shares over 20% at the 2026-06-16 meeting.

“Proposal 3 For Against Abstain/Withheld Approval of the terms of securities purchase agreements entered into between the Company and certain institutional investors (the “ Investors ”) in 2025 and 2026, the transactions contemplated thereby (the “ Transactions ”), and the issuance of shares of common stock to the Investors in the Transactions equal to 20% or more of the Company’s common stock. 10,076,231 1,127,018 421,854”

SurgePays, Inc. shareholders approved Ratification of the appointment of TAAD, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“Proposal 2 For Against Abstain/Withheld Ratification of the appointment of TAAD, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. 15,872,799 1,389,370 13,629”

SurgePays, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Proposal 1 For Against Abstain/Withheld Election of Directors Kevin Brian Cox 10,084,499 0 1,540,604 David N. Keys 9,956,546 0 1,668,557 David May 10,015,873 0 1,609,230 Laurie Weisberg 9,843,283 0 1,781,820”

AH Realty Trust, Inc. shareholders approved Advisory vote on the compensation of the named executive officers as disclosed in the Proxy Statement at the 2026-06-17 meeting.

“Proposal 3 (Advisory Vote on Executive Compensation) — The Company’s stockholders approved, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The following table sets forth the voting results for this proposal: For Against Abstentions Broker Non-Votes 41,684,017 4,811,520 338,681 16,092,972”

AH Realty Trust, Inc. shareholders approved Ratification of KPMG LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2 (Ratification of KPMG LLP) — The Company’s stockholders approved the proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026. The following table sets forth the voting results for this proposal: For Against Abstentions 57,172,251 5,665,661 89,278”

AH Realty Trust, Inc. shareholders approved Election of nine directors to serve until the 2027 annual meeting or until successors are elected and qualified at the 2026-06-17 meeting.

“Proposal 1 (Election of Directors) — The Company’s stockholders elected the following nine persons as directors of the Company, each to serve as such until the Company’s annual meeting of stockholders to be held in 2027, or until his or her respective successor is duly elected and qualified. The following table sets forth the voting results for each director nominee: Director Nominee For Against Abstentions Broker Non-Votes Theodore R. Bigman 44,610,529 2,098,434 125,255 16,092,972 Jennifer R. Boykin 44,064,024 2,704,352 65,842 16,092,972 James A. Carroll 44,303,870 2,478,760 51,588 16,092,972 James C. Cherry 40,453,492 6,326,369 54,357 16,092,972 Louis S. Haddad 40,947,623 5,833,023 53,572 16,092,972 Daniel A. Hoffler 40,921,186 5,847,826 65,206 16,092,972 Shawn J. Tibbetts 44,042,891 2,740,098 51,229 16,092,972 F. Blair Wimbush 42,823,422 3,939,995 70,801 16,092,972 Lori B. Wittman 44,533,604 2,176,070 124,544 16,092,972”

GrowGeneration Corp. shareholders approved Ratification of appointment of BDO USA, P.C. as independent registered public accounting firm for fiscal year 2026 at the 2026-06-18 meeting.

“Proposal 4 – Independent Auditor. The appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm to audit the Company’s financial statements as of December 31, 2026 and for the fiscal year then ending was approved. For Against Abstain Broker Non-Votes 32,361,148 554,290 155,100 —”

GrowGeneration Corp. shareholders approved Amendment of Second Amended and Restated 2018 Equity Incentive Plan to increase share reserve at the 2026-06-18 meeting.

“Proposal 3 – Equity Plan Amendment. The amendment of the Company’s Second Amended and Restated 2018 Equity Incentive Plan to increase the total number of shares issuable under the plan, was approved and became effective as of June 18, 2026. For Against Abstain Broker Non-Votes 13,652,370 2,267,747 166,020 16,984,401”

GrowGeneration Corp. shareholders approved Advisory vote on the compensation of named executive officers (Say-on-Pay) at the 2026-06-18 meeting.

“Proposal 2 – Say-on-Pay. The compensation of the Company’s named executive officers was approved on an advisory basis. For Against Abstain Broker Non-Votes 14,515,031 1,518,422 52,684 16,984,401”

GrowGeneration Corp. shareholders approved Election of five directors to serve until the 2027 Annual Meeting at the 2026-06-18 meeting.

“Proposal 1 – Election of Directors. The five individuals listed below were elected to the Board of Directors of the Company to serve until the Company’s 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.”

Evolv Technologies Holdings, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-06-18 meeting.

“Item 3 - Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 137,633,782 630,689 671,908 0”

Evolv Technologies Holdings, Inc. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. at the 2026-06-18 meeting.

“Item 2 - Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 94,695,112 1,020,267 1,003,044 42,217,956”

Evolv Technologies Holdings, Inc. shareholders approved Election of four Class II directors at the 2026-06-18 meeting.

“Item 1 - Election of four Class II directors to serve until the Company’s annual meeting of stockholders to be held in 2029. Votes FOR Votes WITHHELD Broker Non-Votes Neil Glat 75,654,804 21,063,619 42,217,956 Richard Shapiro 71,810,322 24,908,101 42,217,956”

Cronos Group Inc. shareholders approved Ratification of independent auditor at the 2026-06-18 meeting.

“Proposal No. 4: Appointment of Davidson & Company LLP, the Company’s independent registered public accounting firm, to serve as the Company’s independent auditor for fiscal year 2026 and to authorize the Board of Directors of the Company to fix the independent auditors’ remuneration For Withheld 268,504,336 3,324,423”

Cronos Group Inc. shareholders approved Advisory vote on frequency of say-on-pay at the 2026-06-18 meeting.

“Proposal No. 3: Adoption of an advisory (non-binding) resolution on the frequency of future “say on pay” votes as described in the Proxy Statement One Year Two Years Three Years Abstain 207,874,325 108,955 3,074,365 10,739,000”

Cronos Group Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-18 meeting.

“Proposal No. 2: Adoption of an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers For Against Abstained Broker Non-Votes 219,776,593 1,624,630 395,422 50,032,114”

Cronos Group Inc. shareholders approved Election of Directors at the 2026-06-18 meeting.

“Proposal No. 1: Election of Directors Name of Nominee For Withheld Broker Non-Votes Jason Adler 220,505,353 1,291,292 50,032,114 Darren Broughton 220,506,387 1,290,258 50,032,114 Murray Garnick 219,627,749 2,168,896 50,032,114 Michael Gorenstein 207,751,369 14,045,276 50,032,114 Dominik Meier 220,426,444 1,370,201 50,032,114 James Rudyk 216,463,958 5,332,687 50,032,114 Elizabeth Seegar 220,476,757 1,319,888 50,032,114”

nCino, Inc. shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to permit stockholders to remove any director with or without cause at the 2026-06-18 meeting.

“Proposal 4: Approval of an amendment to the Company’s Certificate of Incorporation to permit stockholders to remove any director with or without cause. Votes For Votes Against Votes Abstained Broker Non-Votes 86,731,161 160,872 10,260 9,629,010 Based on the votes set forth above, the stockholders approved the Amendment to the Company’s Charter to permit stockholders to remove any director with or without cause.”

nCino, Inc. shareholders approved Advisory vote to approve the compensation paid to the Company’s named executive officers at the 2026-06-18 meeting.

“Proposal 3: Advisory vote to approve the compensation paid to the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Votes 75,668,064 7,513,803 3,720,426 9,629,010 Based on the votes set forth above, the stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers.”

nCino, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027 at the 2026-06-18 meeting.

“Proposal 2: Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027. Votes For Votes Against Votes Abstained 96,196,995 321,399 12,909 Based on the votes set forth above, the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027 was ratified.”

nCino, Inc. shareholders approved Election of three directors to hold office for one-year terms and one Class II director to hold office for a two-year term until each of their respective successors are elected and qualified, or their earlier death, resignation or removal at the 2026-06-18 meeting.

“Proposal 1: Election of three directors to hold office for one-year terms and one Class II director to hold office for a two-year term until each of their respective successors are elected and qualified, or their earlier death, resignation or removal. Votes For Votes Against Votes Abstained Broker Non-Votes Jon Doyle 56,634,108 26,482,385 3,785,800 9,629,010 William Spruill 57,843,009 25,273,467 3,785,817 9,629,010 Diego Dugatkin 86,043,323 838,911 20,059 9,629,010 Andy Yasutake (Class II) 86,188,762 693,405 20,126 9,629,010 Based on the votes set forth above, each of the director nominees were duly elected.”

MARA Holdings, Inc. shareholders approved Approval of Amendment to the 2018 Plan at the 2026-06-18 meeting.

“The stockholders approved the Amendment. Shares Voted For Against Abstentions Broker Non-Votes 83,714,947 26,423,491 436,993 102,823,665”

MARA Holdings, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Named Executive Officers at the 2026-06-18 meeting.

“The stockholders approved, on a non-binding advisory basis, the compensation of the Named Executive Officers. Shares Voted For Against Abstentions Broker Non-Votes 64,973,538 44,975,240 626,653 102,823,665”

MARA Holdings, Inc. shareholders approved Ratification of Appointment of Accounting Firm at the 2026-06-18 meeting.

“The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Shares Voted For Against Abstentions 208,334,659 4,190,775 873,662”

MARA Holdings, Inc. shareholders approved Election of Class III Directors at the 2026-06-18 meeting.

“The stockholders elected the following nominees as Class III directors to serve until the Company’s annual meeting of stockholders to be held in 2029, or until their successors are duly elected and qualified, or until their earlier death, resignation or removal. Shares Voted Name For Withheld Broker Non-Votes Vicki Mealer-Burke 65,489,872 45,085,559 102,823,665 Douglas Mellinger 100,494,708 10,080,723 102,823,665”

Eledon Pharmaceuticals, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-18 meeting.

“The results of the stockholders’ vote with respect to the ratification were as follows: For Against Abstain Broker Non-Vote 56,010,539 252,240 76,099 0”

Eledon Pharmaceuticals, Inc. shareholders approved Approval of amendment to Certificate of Incorporation to increase authorized shares of common stock from 300,000,000 to 450,000,000 shares at the 2026-06-18 meeting.

“The results of the stockholders’ vote with respect to the approved amendment were as follows: For Against Abstain Broker Non-Vote 52,305,057 3,739,735 294,086 0”

Eledon Pharmaceuticals, Inc. shareholders approved Election of Class III Directors at the 2026-06-18 meeting.

“The results of the stockholders’ vote with respect to the election of the Class III Directors were as follows: Nominee Term Expiring For Withhold Broker Non-Vote David-Alexandre C. Gros, M.D. 2029 36,633,821 426,888 19,278,169 Jan Hillson, M.D. 2029 33,081,275 3,979,434 19,278,169 James Robinson 2029 30,916,807 6,143,902 19,278,169”

EMPIRE PETROLEUM CORP shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“Proposal Four – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders voted to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026. The results of the vote were as follows: For Against Abstain Broker Non-Votes 30,104,778 2,163 301,907 -0-”

EMPIRE PETROLEUM CORP shareholders approved Approval of the Empire Petroleum Corporation 2026 Stock and Incentive Compensation Plan at the 2026-06-17 meeting.

“Proposal Three – Approval of the Empire Petroleum Corporation 2026 Stock and Incentive Compensation Plan The stockholders voted to approve the 2026 Plan. The results of the vote were as follows: For Against Abstain Broker Non-Votes 20,679,661 489,113 1,064 9,239,010”

EMPIRE PETROLEUM CORP shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-06-17 meeting.

“Proposal Two — Advisory Vote to Approve Named Executive Officer Compensation The stockholders voted to approve, on an advisory basis, named executive officer compensation. The results of the vote were as follows: For Against Abstain Broker Non-Votes 20,676,312 425,115 68,411 9,239,010”

EMPIRE PETROLEUM CORP shareholders approved Election of three directors to serve for a term expiring at the annual meeting of stockholders in 2027 at the 2026-06-17 meeting.

“Proposal One — Election of Directors The stockholders voted to elect three directors to serve for a term expiring at the annual meeting of stockholders in 2027 and until their successors are duly elected and qualified. The results of the vote were as follows: For Withheld Broker Non-Votes Michael R. Morrisett 20,291,265 878,573 9,239,010 Vice Admiral Andrew L. Lewis (Ret.) 20,509,740 660,098 9,239,010 J. Kevin Vann 20,564,930 604,908 9,239,010”

Atea Pharmaceuticals, Inc. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. at the 2026-06-18 meeting.

“Proposal 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. FOR AGAINST ABSTAIN BROKER NON-VOTE 47,452,759 2,977,290 643,628 8,669,142”

Atea Pharmaceuticals, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-06-18 meeting.

“Proposal 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. FOR AGAINST ABSTAIN BROKER NON-VOTE 58,894,207 783,081 65,531 0”

Atea Pharmaceuticals, Inc. shareholders approved Election of three Class III Directors to serve until the 2029 annual meeting of stockholders, and until their respective successors have been duly elected and qualified. at the 2026-06-18 meeting.

“Proposal 1 — Election of three Class III Directors to serve until the 2029 annual meeting of stockholders, and until their respective successors have been duly elected and qualified. FOR WITHHOLD BROKER NON-VOTE Jerome Adams, MD, MPH 28,798,012 22,275,665 8,669,142 Howard Berman, PhD 44,466,627 6,607,050 8,669,142 Barbara Duncan 43,697,098 7,376,579 8,669,142”

CytomX Therapeutics, Inc. shareholders approved Non-binding advisory vote on the frequency of future advisory votes on executive compensation at the 2026-06-17 meeting.

“Proposal 7. The non-binding, advisory vote regarding the frequency of future advisory votes by stockholders on the compensation of the Company’s named executive officers: 1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTES 145,004,404 1,298,607 2,352,377 349,574 34,599,122”

CytomX Therapeutics, Inc. shareholders approved Non-binding advisory vote on the compensation of the named executive officers (Say-on-Pay) at the 2026-06-17 meeting.

“Proposal 6. The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, pursuant to the compensation disclosure rules of the SEC. FOR AGAINST ABSTAIN BROKER NON-VOTES 147,127,715 1,722,679 154,568 34,599,122”

CytomX Therapeutics, Inc. shareholders approved Approval of an amendment to the Amended and Restated Employee Stock Purchase Plan at the 2026-06-17 meeting.

“Proposal 5. The Company’s stockholders approved an amendment to the Company’s Amended and Restated Employee Stock Purchase Plan, as described in the Proxy Statement. FOR AGAINST ABSTAIN BROKER NON-VOTES 147,375,197 1,468,576 161,189 34,599,122”

CytomX Therapeutics, Inc. shareholders approved Approval of an amendment to the 2015 Plan at the 2026-06-17 meeting.

“Proposal 4. The Company’s stockholders approved an amendment to the 2015 Plan, as described in the Proxy Statement. FOR AGAINST ABSTAIN BROKER NON-VOTES 147,079,951 1,745,001 180,010 34,599,122”

CytomX Therapeutics, Inc. shareholders approved Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase authorized shares of common stock from 300,000,000 to 600,000,000 at the 2026-06-17 meeting.

“Proposal 3. The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares. FOR AGAINST ABSTAIN 178,362,995 4,771,689 469,400”

CytomX Therapeutics, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm at the 2026-06-17 meeting.

“Proposal 2. The Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. FOR AGAINST ABSTAIN 182,976,052 382,681 245,351”

CytomX Therapeutics, Inc. shareholders approved Election of Class II director nominees to the Board to hold office until the 2029 Annual Meeting at the 2026-06-17 meeting.

“Proposal 1. The Company’s stockholders elected the Class II director nominees below to the Board to hold office until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or the earlier of their death, resignation or removal. NOMINEE FOR AGAINST ABSTAIN BROKER NON-VOTES Matthew P. Young 146,742,827 2,062,471 199,664 34,599,122 Elaine V. Jones Ph.D. 131,377,301 17,428,951 198,710 34,599,122”

OneMain Holdings, Inc. shareholders approved to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“5. Auditor Ratification Proposal: FOR AGAINST ABSTAIN BROKER NON-VOTES 100,910,258 1,883,306 120,995 —”

OneMain Holdings, Inc. shareholders approved to approve the OneMain Holdings, Inc. 2026 Omnibus Incentive Plan at the 2026-06-16 meeting.

“4. Incentive Plan Proposal: FOR AGAINST ABSTAIN BROKER NON-VOTES 88,538,932 3,200,586 182,913 10,992,128”

OneMain Holdings, Inc. shareholders approved to approve, on an advisory basis, the frequency of future advisory votes to approve the compensation paid to our named executive officers at the 2026-06-16 meeting.

“3. Say on Pay Frequency Proposal: 1 YEAR 2 YEAR 3 YEAR ABSTAIN BROKER NON-VOTES 86,819,503 82,793 4,794,037 226,098 10,992,128”

OneMain Holdings, Inc. shareholders approved to approve, on an advisory basis, the compensation paid to the Company's named executive officers at the 2026-06-16 meeting.

“2. Say on Pay Proposal: FOR AGAINST ABSTAIN BROKER NON-VOTES 89,106,624 2,599,910 215,897 10,992,128”

OneMain Holdings, Inc. shareholders approved to elect Phyllis R. Caldwell and Roy A. Guthrie as Class I directors at the 2026-06-16 meeting.

“1. Director Election Proposal: FOR AGAINST ABSTAIN BROKER NON-VOTES Phyllis R. Caldwell 79,281,735 12,532,747 107,949 10,992,128 Roy A. Guthrie 89,664,703 2,173,766 83,962 10,992,128”

GRAIL, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.

“The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal received the following votes: Votes For Votes Against Abstentions Broker Non-Votes 34,611,318 57,682 407,394 0”

GRAIL, Inc. shareholders approved Election of two Class II Directors to serve until the Annual Meeting of Stockholder to be held in 2029 and until their successors are duly elected and qualified at the 2026-06-18 meeting.

“The Company’s stockholders elected two Class II Directors to serve until the Annual Meeting of Stockholder to be held in 2029 and until their successors are duly elected and qualified. The votes regarding the election of the directors were as follows: Name Votes For Withheld Broker Non-Votes Sarah Krevans 18,929,398 2,972,804 13,174,192 Steven Mizell 16,998,081 4,904,121 13,174,192”

EQUITY RESIDENTIAL shareholders approved Advisory Approval of Executive Compensation at the 2026-06-18 meeting.

“Proposal 3 – Advisory Approval of Executive Compensation The shareholders approved, on an advisory basis, the executive compensation disclosed in the Proxy Statement, by the votes set forth below. For 303,275,382 Against 34,423,665 Abstain 706,826 Broker Non-Votes 15,241,514”